Literature DB >> 11325215

Hyperthermia-induced cell death by apoptosis in myeloma cells.

S Barni1, P Pontiggia, V Bertone, R Vaccarone, M G Silvotti, E Pontiggia, G Mathé.   

Abstract

We have analyzed by morphological (TEM) and histochemical (TUNEL reaction) criteria the type of cell death occurring in one case of human multiple myeloma after hyperthermia. Samples of cells examined immediately at the end of two treatments with a 15-day interval showed a significant degeneration, mostly demonstrating features of apoptosis (cell shrinkage, DNA fragmentation, karyorrhexis). The possible causes of the lag period between heating and apoptosis onset-expression are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11325215     DOI: 10.1016/s0753-3322(01)00043-9

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Different apoptotic responses and patterns in adhering and floating neoplastic cell cultures: effects of microtubule antagonists.

Authors:  Luigi Sciola; Alessandra Spano; Gianni Monaco; Maria Grazia Bottone; Sergio Barni
Journal:  Histochem Cell Biol       Date:  2002-12-20       Impact factor: 4.304

2.  Effect of magnetic fluid hyperthermia on lung cancer nodules in a murine model.

Authors:  Runlei Hu; Shenglin Ma; Hu Li; Xianfu Ke; Guoqing Wang; Dongshan Wei; Wei Wang
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

3.  [Effects of magnetic fluid hyperthermia induced by an alternative magnetic field on human carcinoma A549 cell in vitro].

Authors:  Guoqing Wang; Hu Li; Runlei Hu; Xianfu Ke; Dongshan Wei; Wen Meng
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-03

Review 4.  Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.

Authors:  Ga Yeong Yi; Min Ju Kim; Hyo In Kim; Jinbong Park; Seung Ho Baek
Journal:  Antioxidants (Basel)       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.